Aarti Drugs commences new R&D center at MIDC Tarapur

05 May 2014 Evaluate

Aarti Drugs has commenced the new R&D center at MIDC Tarapur. Earlier, on September 26, 2013  US health regulator had issued a warning letter to company's Maharashtra facilities .The investigators of the US Food and Drug Administration had identified significant violations of current good manufacturing practice (CGMP) regulations for finished pharmaceuticals and active pharmaceutical ingredients at the companies Maharashtra facilities.

Aarti Drugs (ADL) is engaged in the business of manufacturing generic bulk actives, advanced intermediates and specialty chemicals. The company is part of $265 million Aarti Group of Industries.

Aarti Drugs Share Price

375.20 1.00 (0.27%)
06-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1694.70
Dr. Reddys Lab 1241.15
Cipla 1330.80
Zydus Lifesciences 887.85
Lupin 2168.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×